CVRx (CVRX) Income from Continuing Operations (2020 - 2026)
CVRx (CVRX) posted Income from Continuing Operations of -$14.0 million for Q2 2026, down 7.04% on a QoQ basis from -$13.1 million in Q1 2026, and up 4.7% year-over-year from -$13.4 million in Q2 2025.
Powered by 
Analysis
CVRx (CVRX) Income from Continuing Operations (2020 - 2026) Analysis & Trends
CVRx has reported Income from Continuing Operations for 7 years, with the latest figure at -$14.0 million in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 4.7% year-over-year to -$14.0 million in Q2 2026; TTM through Jun 2026 was -$40.8 million, a 2.93% decrease from a year earlier, with the FY2025 full-year figure at -$42.1 million, up 11.02% from the prior year.
- Income from Continuing Operations was -$14.0 million for Q2 2026 at CVRx, down from -$13.1 million in the prior quarter.
- The five-year high for Income from Continuing Operations was $2.0 million in Q4 2024, with the low at -$22.2 million in Q1 2024.
- Average Income from Continuing Operations over 5 years is -$11.1 million, with a median of -$11.5 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations jumped 121.53% in 2024, then sank 138.22% in 2025.
- Over 5 years, Income from Continuing Operations stood at -$10.5 million in 2022, then advanced by 13.03% to -$9.2 million in 2023, then surged by 121.53% to $2.0 million in 2024, then tumbled by 138.22% to -$754000.0 in 2025, then sank by 1762.6% to -$14.0 million in 2026.
- The last three Income from Continuing Operations figures came in at -$14.0 million (Q2 2026), -$13.1 million (Q1 2026), and -$754000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | CVRx | 75.57 Mn | 10.98 Mn | 13.72 Mn | -14.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.04 Mn |
| Mar 31, 2026 | -13.12 Mn |
| Dec 31, 2025 | -754,000.00 |
| Sep 30, 2025 | -12.87 Mn |
| Jun 30, 2025 | -14.74 Mn |
| Mar 31, 2025 | -13.77 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | -13.10 Mn |
| Jun 30, 2024 | -14.03 Mn |
| Mar 31, 2024 | -22.19 Mn |
| Dec 31, 2023 | -9.16 Mn |
| Sep 30, 2023 | -9.01 Mn |
| Jun 30, 2023 | -11.65 Mn |
| Mar 31, 2023 | -11.37 Mn |
| Dec 31, 2022 | -10.54 Mn |
| Sep 30, 2022 | -9.83 Mn |
| Jun 30, 2022 | -11.07 Mn |
| Mar 31, 2022 | -9.99 Mn |
| Dec 31, 2021 | -10.57 Mn |
| Sep 30, 2021 | -6.13 Mn |